SANTA ANA, Calif. — Court adjourned Wednesday in the first week of the long-anticipated civil trial brought by the family of Tyler Skaggs against the Los Angeles Angels. Tyler Skaggs was a former ...
SynOx Therapeutics completed enrollment for the phase 3 TANGENT study of emactuzumab for tenosynovial giant cell tumors, with results expected in 2026. ALX Oncology launched a phase 1 trial of ALX2004 ...
Over the year multiple clinical trial readouts validated the use of MRD for multiple indications, while companies in the space began to consolidate.
Indaptus Therapeutics announced significant progress in its Phase 1 trial of Decoy20, with over 20 patients enrolled in the weekly dosing cohort. Initial clinical data shows promising pharmacodynamic ...
A longtime traveling secretary of the Angels testified in the Tyler Skaggs wrongful death trial on Monday. Kirby Lee / USA TODAY Sports SANTA ANA, Calif. — The second week of testimony in the wrongful ...
Protara Therapeutics reports positive six-month ADVANCED-2 trial data for TARA-002 and plans 2025 milestones for ongoing trials. Protara Therapeutics, Inc. announced positive six-month findings from ...
What just happened? Gerard Williams III, one of the lead developers behind Oryon and a variety of Apple's processors, has provided crucial testimony in a trial over whether Qualcomm's existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback